Wells Fargo & Company Werewolf Therapeutics, Inc. Call Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HOWL
# of Institutions
76Shares Held
32.1MCall Options Held
53.8KPut Options Held
1.3K-
Ra Capital Management, L.P. Boston, MA6.14MShares$13.9 Million0.23% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.28MShares$9.68 Million5.74% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.24MShares$7.32 Million0.41% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.39MShares$5.4 Million0.94% of portfolio
-
Bank Of America Corp Charlotte, NC2.15MShares$4.85 Million0.0% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $66.7M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...